Sebastien Hazard
Chief Tech/Sci/R&D Officer bei IMUNON, INC.
Vermögen: 32 800 $ am 31.03.2024
Profil
Sebastien Hazard is currently the Chief Medical Officer & Executive Vice President at Imunon, Inc. Prior to his current position, he held the role of Senior Medical Director-Clinical Development at Tesaro, Inc. from 2016 to 2019.
From 2019 to 2021, he served as the Head-Clinical Development at GSK Plc.
Dr. Hazard then joined Bicycle Therapeutics Plc in 2021 as the Senior VP & Head-Clinical Development, a position he held until 2023.
Hazard obtained an MBA from INSEAD.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
IMUNON, INC.
0,21% | 07.12.2023 | 20 000 ( 0,21% ) | 32 800 $ | 31.03.2024 |
Aktive Positionen von Sebastien Hazard
| Unternehmen | Position | Beginn |
|---|---|---|
| IMUNON, INC. | Chief Tech/Sci/R&D Officer | 11.12.2023 |
Ehemalige bekannte Positionen von Sebastien Hazard
| Unternehmen | Position | Ende |
|---|---|---|
| BICYCLE THERAPEUTICS PLC | Corporate Officer/Principal | 01.09.2023 |
| GSK PLC | Chief Tech/Sci/R&D Officer | 01.04.2021 |
| TESARO INC | Chief Tech/Sci/R&D Officer | 01.05.2019 |
Ausbildung von Sebastien Hazard
| INSEAD | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| IMUNON, INC. | Health Technology |
| GSK PLC | Health Technology |
| BICYCLE THERAPEUTICS PLC | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA. | Health Technology |
